Led · Series A · Feb 2026

Founded in 1960, Jain Cord Industries operates a fully integrated textile production chain that spans weaving, knitting, dyeing, finishing, and garment manufacturing. The company is best known for its woven fabrics such as corduroy and velveteen and runs large-scale facilities in Gurugram and Kosi near Mathura. Leveraging modern production technologies and strict compliance standards, it supplies fabric and finished garments to both Indian and global fashion labels. For FY25, Jain Cord generated revenue of Rs 783.33 crore, up sharply from Rs 537.37 crore in FY24, while profit rose to Rs 19.97 crore from Rs 12.52 crore. Management plans to channel new capital into working capital, debt repayment, capex, and expansion initiatives to capture additional market share. Following its first institutional raise, Indorama Capital now owns 24.13% of the company, valuing the business at about Rs 829 crore post-money. With a history of process-driven operations and a growing order book, Jain Cord aims to scale production capacity and broaden its product portfolio in the coming years.

Led · Series B · Apr 2023

Polymateria develops a biotransformation technology that safely returns commonly polluted plastic items to nature without leaving microplastics or toxic residue. The company was established at Imperial College London and is led by Lee Davy-Martin. It has gained commercial traction with customers worldwide, including Twickenham Rugby Stadium, the Chicago Marathon and 7‑ELEVEN Taiwan. Polymateria raised £20M in Series B funding to accelerate commercialization of its technology at scale. The company plans to use the funds to invest in its people and R&D capabilities and to boost its in‑house laboratory at Imperial College London. It also intends to increase penetration in existing markets and expand into new markets where fugitive plastic pollution is most acute, including further development in Asia. Polymateria develops a Biotransformation technology that fully biodegrades common plastics and, the company says, leaves behind zero microplastics with no environmental harm. Its core products include Cycle+, a recyclable material that biodegrades after about three years, and DegrAid, designed to break down within six months for single-use litter. The startup works across chemistry, biology and polymer science in collaboration with Imperial College London. It has won two Innovate UK research grants to develop Biotransformation for PET and a petro-plastic that meets international standards for home and industrial composting. Polymateria positions its materials as compatible with recycling during useful life while addressing end-of-life pollution where recycling is not an option. The company emphasizes third-party testing and says the technology can scale without significant capital cost to industry.

Participated · Series B · Jan 2022

Remilk is a Tel Aviv–based food startup that produces dairy-identical milk proteins through a fermentation process. The company has developed a patented approach to scalable manufacturing that it says increases production efficiency and removes the need for dairy cows at industrial scale without compromising taste, functionality, or nutritional values. Remilk intends to scale production for commercial use by manufacturers of traditionally dairy-based products, including cheeses, yogurt, and ice cream. The company is positioned as a global leader in the development of animal-free dairy. Remilk was co-founded by Aviv Wolff, an entrepreneur with experience at several startups, and Ori Cohavi, PhD in biochemistry, who has worked in R&D at various biotech firms. The article reports a significant Series B financing that will support the company’s production scale-up plans. Remilk develops animal-free dairy by producing identical dairy proteins via a proprietary, patented microbial fermentation process. Its lab-made dairy proteins are designed to be functionally and sensorially identical to natural dairy and are used as starting materials by commercial manufacturers for cheese, yogurt and cream production. The company says its products are cholesterol-free and contain no lactose, antibiotics or growth hormones. Remilk highlights sustainability advantages, claiming its process requires 1% of the land, 4% of the feedstock and 10% of the water compared with traditional dairy. With new production and distribution partnerships, Remilk plans rapid expansion to meet global demand and to enable industrial-scale, cow-free dairy protein production.